Ferrocene-chloroquine analogues as antimalarial agents: In vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 2, 2001, Pages 179-184

  Pradines, B ^a   Fusai, T ^a   Daries, W ^a   Laloge, V ^b   Rogier, C ^a   Millet, P ^c   Panconi, E ^d   Kombila, M ^e   Parzy, D ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b 6ième Bataillon d'Infanterie de Marine   (Gabon)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^e UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 4 [(2 N,N' DIMETHYLAMINOMETHYL)FERROCENYLMETHYLAMINO]QUINOLINE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; ATOVAQUONE; CHLOROQUINE; FERROCENE DERIVATIVE; HALOFANTRINE; MEFLOQUINE; PRIMAQUINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS RESISTANCE; DRUG ACTIVITY; DRUG STRUCTURE; GABON; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; ISOLATION PROCEDURE; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM;

EID: 0034883927     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.2.179     Document Type: Article

References (37)

1. The development and spread of drug-resistant malaria
2. Impact of chloroquine resistance on malaria mortality
3. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya
4. Mefloquine failure in child contracting falciparum malaria in West Africa
5. Failure of anti-malarial prophylaxis with mefloquine in Africa
6. Type RI resistance to halofantrine in West Africa
7. Quinine resistant falciparum malaria acquired in East Africa
8. Paludisme à Plasmodium falciparum: Résistance de type RI à la quinine en Afrique de l'Est
9. New targets for antimalarial drug discovery
10. Role of iron in microbe-host interactions
11. Iron chelation as a chemotherapeutic strategy for falciparum malaria
12. In vitro activities of novel catecholate siderophore against Plasmodium falciparum
13. The treatment of malaria with iron chelators
14. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue
15. Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds
16. Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine
17. In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine
18. Susceptibility of human malaria parasites to chloroquine is pH dependent
19. Antimalarials increase vesicle pH in Plasmodium falciparum
20. Antimalarial schizonticides: Ferriprotoporphyrin IX interaction hypothesis
21. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
22. Malarial haemozoin/α-hematin supports haem polymerization in the absence of protein
23. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
24. A P-glycoprotein homologue of Plasmodium falciparum is isolated on the digestive vacuole
25. The rôle of molecular genetics in field studies in malaria parasites
26. Complex polymorphisms in a approximately 330 kDa protein are linked to chloroquine resistant Plasmodium falciparum in Southeast Asia and Africa
27. 4-aminoquinoline resistance of Plasmodium falciparum: Insights from the study of amodiaquine uptake
28. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa
29. Evidence for selection for the tyrosine 86 allele of pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine
30. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials
31. Site of action of the antimalarial hydroxynaphthoquinone, 2-(trans-4(4′-chloro-phenyl) cyclohexyl)-3-hydroxy-1,4-naphthoquinone (566C80)
32. Effects of atovaquone and other inhibitors on Pneumocytis carinii dihydroorotate dehydrogenase
33. DCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess
34. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin
35. The evolution of tafenoquine - Antimalarial for a new millennium?
36. Dipeptide derivatives of primaquine as transmission blocking antimalarials: Effect of aliphatic side-chain acylation on the gametocidal activity and on the formation of carboxyprimaquine in rat liver homogenates
37. Chronic toxicity of dicyclopentadienyl iron (ferrocene) in dogs